232 filings
Page 11 of 12
8-K
an53proph6a693rov
3 Mar 16
ContraVir Pharmaceuticals Reports Positive Results Confirming the Safety of its Shingles Candidate FV-100 in a Drug-Drug Interaction Study
12:00am
8-K
n2i l47qjw
5 Feb 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
yk8701n
5 Jan 16
ContraVir Pharmaceuticals to Present at Biotech Showcase 2016
12:00am
8-K
lbxe8kwt
8 Dec 15
ContraVir Reports Key CMX157 Data at HEP DART 2015
12:00am
8-K
nzm71 k349vm
3 Dec 15
Departure of Directors or Certain Officers
12:00am
8-K
7qesgt
1 Dec 15
ContraVir to Present New CMX157 Data at HEP DART 2015
12:00am
8-K
dn1w88190lrtjkiq
20 Nov 15
Departure of Directors or Certain Officers
12:00am
8-K
ub56k8
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
0lexv8q 98btq47
5 Oct 15
Other Events
12:00am
8-K
r9r bk328m
4 Aug 15
ContraVir Pharmaceuticals Enrolls First Patient in Pivotal Phase 3 Study of FV-100 for Treatment of Shingles and Shingles-Associated Pain
12:00am
8-K
wz05sys
3 Jun 15
ContraVir Engages the Baruch S. Blumberg Institute to Further Research and Develop CMX157
12:00am
8-K
ynhd8
28 May 15
Other Events
12:00am
8-K
2dsxaf4g67laoje0y
9 Mar 15
ContraVir Pharmaceuticals to Initiate Pivotal Phase 3 Study of FV-100 for Prevention of Shingles-Associated PHN
12:00am
8-K
g7eaz s7ytep9yi
4 Mar 15
Unregistered Sales of Equity Securities
12:00am
8-K
9jdwb
25 Feb 15
ContraVir Pharmaceuticals Announces Uplisting to The NASDAQ Capital Market
12:00am
8-K
n88eaw
20 Feb 15
ContraVir Pharmaceuticals Provides Clinical Update on FV-100
12:00am
8-K
ea3baqd xy4eew9t5
4 Feb 15
ContraVir Pharmaceuticals’ HBV Compound CMX157 Receives Extended Patent Life
12:00am
8-K
07imu
20 Jan 15
ContraVir Pharmaceuticals Adds Carol L. Brosgart, M.D., to Scientific Advisory Board
12:00am
8-K
zkv1 u77xsb493
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
8-K
32qlpg
8 Jan 15
ContraVir Pharmaceuticals adds Renu Gupta, M.D., to Scientific Advisory Board
12:00am